Target RWE

Acquired

Durham, United States · Founded 2015

Employees
51–200
Founded
2015
Business Model
B2B
Last Round
Venture RoundJan 2025
Rounds
1

About

Target RWE generates complete, longitudinal real-world datasets using advanced analytics and causal inference methodologies to support biopharma and medical device clients across R&D, medical affairs, HEOR, regulatory, and commercial functions. The company operates patient registries in collaboration with leading academic clinical investigators, capturing retrospective and prospective follow-up data. Its proprietary causalRisk™ and causalPHR™ software platforms deliver validated analytics and interactive data visualization for evidence generation.

Summary

Target RWE is a Biotech company based in Durham, United States, founded in 2015. Its most recent funding was a Venture Round round in Jan 2025. Investors include 22C Capital.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Venture RoundVenture RoundJan 2025

Investors

Similar Companies